- Conditions
- Percutaneous Coronary Intervention, Coronary Artery Disease (CAD), Angioplasty
- Interventions
- PMX-60056
- Drug
- Lead sponsor
- PolyMedix, Inc.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 3
- States / cities
- South Bend, Indiana • Detroit, Michigan • Rapid City, South Dakota
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 283
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Coronary Artery Disease, Acute Coronary Syndrome, Stenosis
- Interventions
- Clopidogrel, Ticagrelor
- Drug
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 5,276 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2020
- U.S. locations
- 26
- States / cities
- Scottsdale, Arizona • San Diego, California • San Francisco, California + 20 more
- Conditions
- Microvascular Coronary Artery Disease
- Interventions
- SAR407899, Placebo, Adenosine, Regadenoson, 13N-ammonia, 82Rubidium
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 6
- States / cities
- Los Angeles, California • Jacksonville, Florida • Wellington, Florida + 3 more
- Conditions
- Coronary Arteriosclerosis, Non ST Segment Elevation Acute Coronary Syndrome
- Interventions
- OrbusNeich Combo stent™, Everolimus Eluting Stent (EES)
- Device
- Lead sponsor
- OrbusNeich
- Industry
- Eligibility
- 20 Years and older
- Enrollment
- 572 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2021
- U.S. locations
- 17
- States / cities
- Washington D.C., District of Columbia • Lake Worth, Florida • Miami, Florida + 14 more
- Conditions
- Acute Myocardial Infarction
- Interventions
- Intensive insulin therapy
- Drug
- Lead sponsor
- Emory University
- Other
- Eligibility
- 18 Years to 89 Years
- Enrollment
- 58 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2006
- U.S. locations
- 2
- States / cities
- Atlanta, Georgia
- Conditions
- Coronary Artery Disease, High-risk Percutaneous Coronary Intervention, Interventional Cardiology
- Interventions
- Supira System
- Device
- Lead sponsor
- Supira Medical
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 4
- States / cities
- Sacramento, California • Atlanta, Georgia • New York, New York + 1 more
- Conditions
- Coronary Artery Disease
- Interventions
- Robotic-assisted PCI
- Device
- Lead sponsor
- Siemens Healthineers Endovascular Robotics, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 952 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 17
- States / cities
- San Diego, California • Washington D.C., District of Columbia • Grand Rapids, Michigan + 14 more
- Conditions
- Myocardial Infarction
- Interventions
- BB3, Normal saline
- Drug
- Lead sponsor
- Angion Biomedica Corp
- Industry
- Eligibility
- 21 Years to 80 Years
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 2
- States / cities
- Minneapolis, Minnesota • New Haven, New York
- Conditions
- Ethics, Cardiac Rehabilitation, Coronary Heart Disease (CHD), Heart Failure, Percutaneous Coronary Intervention (PCI), Aortic Valve Replacement, Myocardial Infarction (MI)
- Interventions
- Usual Care Group, More Support and Tools
- Behavioral
- Lead sponsor
- Baystate Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 160 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Springfield, Massachusetts
- Conditions
- Coronary Artery Stenosis
- Interventions
- State-of-the-Art Percutaneous Coronary Intervention, standard CABG
- Procedure
- Lead sponsor
- Duk-Woo Park, MD
- Other
- Eligibility
- 20 Years and older
- Enrollment
- 1,500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2029
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Diabetes Mellitus, Type 2, Coronary Artery Disease
- Interventions
- Ticagrelor monotherapy, Ticagrelor plus aspirin, Clopidogrel with aspirin
- Drug
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 105 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 1
- States / cities
- Jacksonville, Florida
- Conditions
- Ventricular Tachycardia
- Interventions
- Circulatory Support System
- Device
- Lead sponsor
- Vivek Reddy
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Acute Coronary Disease, Angina Unstable
- Interventions
- Clopidogrel, acetylsalicyclic acid (ASA)
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 25,086 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2009
- U.S. locations
- 1
- States / cities
- Bridgewater, New Jersey
- Conditions
- Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI)
- Interventions
- Prasugrel, Clopidogrel
- Drug
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Jacksonville, Florida
- Conditions
- Myocardial Infarction
- Interventions
- abciximab placebo; reteplase placebo, abciximab, abciximab, Abciximab; reteplase; abciximab placebo; abciximab, abciximab; reteplase placebo; abciximab placebo; abciximab
- Drug
- Lead sponsor
- Centocor, Inc.
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 2,461 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2008
- U.S. locations
- 52
- States / cities
- Phoenix, Arizona • Covina, California • Modesto, California + 49 more
- Conditions
- Percutaneous Coronary Intervention
- Interventions
- Wellframe
- Other
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 21 Years to 85 Years
- Enrollment
- 167 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 2
- States / cities
- Boston, Massachusetts
- Conditions
- Coronary Artery Disease, Myocardial Ischemia, Bleeding
- Interventions
- clopidogrel 600 mg, arterial access sheath
- Drug · Device
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Coronary Disease
- Interventions
- Self Monitoring Software Application
- Device
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years to 100 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Coronary Artery Bypass Graft Surgery
- Interventions
- bypass graft angiography
- Procedure
- Lead sponsor
- North Texas Veterans Healthcare System
- Federal
- Eligibility
- 18 Years and older
- Enrollment
- 170 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Stable Coronary Artery Disease, Percutaneous Coronary Intervention
- Interventions
- CMX-2043, Placebo control
- Drug
- Lead sponsor
- Ischemix, LLC
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 142 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 2
- States / cities
- Worcester, Massachusetts • Durham, North Carolina
- Conditions
- Coronary Artery Disease
- Interventions
- Not listed
- Lead sponsor
- Emory University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 5,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2031
- U.S. locations
- 17
- States / cities
- Phoenix, Arizona • Fort Lauderdale, Florida • Atlanta, Georgia + 9 more
- Conditions
- Increased Drug Resistance
- Interventions
- Thienopyridine resistance testing, Aspirin resistance testing, Genetic polymorphism assessment
- Other
- Lead sponsor
- Medstar Health Research Institute
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2016
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Patent Ductus Arteriosus
- Interventions
- Cather closure of patent ductus arteriosus (PDA), Conservative management of patent ductus arteriosus (PDA)
- Device · Other
- Lead sponsor
- Nationwide Children's Hospital
- Other
- Eligibility
- 14 Days to 28 Days
- Enrollment
- 1 participant
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 2
- States / cities
- Columbus, Ohio • Memphis, Tennessee
- Conditions
- High-risk Percutaneous Coronary Intervention
- Interventions
- Impella ECP
- Device
- Lead sponsor
- Abiomed Inc.
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2026
- U.S. locations
- 5
- States / cities
- Boston, Massachusetts • Detroit, Michigan • Paramus, New Jersey + 1 more